Generic pharmaceutical firm Actavis has significantly increased its capability in producing oncology pharmaceuticals with the purchase of a Pfizer manufacturing site. Reykjavik (eNewsWire) 28 January
You May Have Missed
Generic pharmaceutical firm Actavis has significantly increased its capability in producing oncology pharmaceuticals with the purchase of a Pfizer manufacturing site. Reykjavik (eNewsWire) 28 January
